Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Comprehensive Cancer Network
Celgene Corporation
Genentech, Inc.
Information provided by (Responsible Party):
University of Tennessee Cancer Institute
ClinicalTrials.gov Identifier:
NCT00777673
First received: October 20, 2008
Last updated: January 3, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)